CSCS FISSN - Safety Shot Chief Officer
| SHOT Stock | 0.85 0.02 2.41% |
Executive
CSCS FISSN is Chief Officer of Safety Shot
| Age | 54 |
| Address | 1061 East Indiantown Road, Jupiter, FL, United States, 33477 |
| Phone | 561 244 7100 |
| Web | https://safetyshotofficial.com |
Safety Shot Management Efficiency
The company has return on total asset (ROA) of (1.8945) % which means that it has lost $1.8945 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.082) %, meaning that it created substantial loss on money invested by shareholders. Safety Shot's management efficiency ratios could be used to measure how well Safety Shot manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.93 in 2024. Return On Capital Employed is likely to drop to -1.4 in 2024. At this time, Safety Shot's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 669.1 K in 2024, whereas Total Current Liabilities is likely to drop slightly above 2.2 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jemma Spalton | Unilever PLC ADR | N/A | |
| Javier Polit | Procter Gamble | N/A | |
| Steve Winchell | Honest Company | 49 | |
| David Foster | Colgate Palmolive | N/A | |
| Leena Nair | Unilever PLC ADR | 51 | |
| Carlen Hooker | Church Dwight | 53 | |
| Amee Parekh | Hims Hers Health | N/A | |
| Valerie Haliburton | Colgate Palmolive | N/A | |
| Preeti Binoy | Kimberly Clark | N/A | |
| Damon Jones | Procter Gamble | 48 | |
| Susan Whaley | Procter Gamble | 50 | |
| Dan Dahlgren | The Clorox | N/A | |
| Lauren Richardson | Colgate Palmolive | N/A | |
| Deborah Majoras | Procter Gamble | 57 | |
| Soleil Boughton | Hims Hers Health | 45 | |
| Seth Cohen | Procter Gamble | N/A | |
| Mairead Nayager | Unilever PLC ADR | 49 | |
| Erbie Foster | The Clorox | N/A | |
| Vittorio Cretella | Procter Gamble | N/A | |
| Scott Knoer | Hims Hers Health | N/A | |
| Soleil JD | Hims Hers Health | 45 | |
Management Performance
| Return On Equity | -6.08 | ||||
| Return On Asset | -1.89 |
Safety Shot Leadership Team
Elected by the shareholders, the Safety Shot's board of directors comprises two types of representatives: Safety Shot inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safety. The board's role is to monitor Safety Shot's management team and ensure that shareholders' interests are well served. Safety Shot's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safety Shot's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Glynn Wilson, Chief Chairman | ||
| Jarrett Boon, COO Director | ||
| Danielle RosaDiaz, Chief Officer | ||
| Josh Wagner, Chief Officer | ||
| Jordan Schur, President Director | ||
| Andy MD, Chief Board | ||
| Brian John, CEO Director | ||
| Anthony Pedicelli, Director Marketing | ||
| CSCS FISSN, Chief Officer |
Safety Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safety Shot a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.08 | ||||
| Return On Asset | -1.89 | ||||
| Operating Margin | (11.85) % | ||||
| Current Valuation | 49.76 M | ||||
| Shares Outstanding | 61.14 M | ||||
| Shares Owned By Insiders | 30.51 % | ||||
| Shares Owned By Institutions | 10.01 % | ||||
| Number Of Shares Shorted | 4.42 M | ||||
| Price To Book | 7.96 X | ||||
| Price To Sales | 49.49 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Safety Stock Analysis
When running Safety Shot's price analysis, check to measure Safety Shot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safety Shot is operating at the current time. Most of Safety Shot's value examination focuses on studying past and present price action to predict the probability of Safety Shot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safety Shot's price. Additionally, you may evaluate how the addition of Safety Shot to your portfolios can decrease your overall portfolio volatility.